Interpreting alkaline phosphatase in clinical practice: integrating analytical advances and physiological context

Area of Science:

• Clinical Biochemistry
• Laboratory Medicine

Background:

• Accurate interpretation of serum alkaline phosphatase (ALP) is vital in clinical practice.
• Advancements in ALP assay techniques, particularly the IFCC reference method, have led to higher measured ALP values.
• This necessitates a reassessment of reference intervals and clinical interpretation guidelines.

Purpose of the Study:

• To integrate analytical developments with physiological context for guiding clinicians in ALP result interpretation.
• To highlight the impact of the IFCC method on ALP values and reference intervals.
• To provide a comprehensive overview of clinical causes for ALP level variations.

Main Methods:

• Review of analytical advancements in ALP assay techniques, focusing on the IFCC reference method.
• Integration of physiological determinants influencing ALP levels (age, gender, pregnancy, BMI, bone density).
• Discussion of clinical conditions associated with elevated and reduced ALP, and diagnostic adjuncts like GGT.

Main Results:

• The IFCC method yields ALP results approximately 10% higher than previous assays.
• This impacts reference interval accuracy and clinical flagging rates.
• Clinical causes of elevated ALP include hepatobiliary and bone disorders, malignancies, and endocrine conditions; reduced ALP may indicate rare genetic, hepatic, or nutritional disorders.

Conclusions:

• Correlating ALP results with clinical context, other lab findings, and updated reference intervals is crucial.
• Ongoing education and harmonization of reference intervals are essential for effective clinical decision-making.
• Ensuring ALP remains a valuable tool in patient assessment requires addressing assay consistency challenges and minimizing unnecessary investigations.